Pharmaceutical company Merck recently announced that the updated data on their experimental Wuhan coronavirus (COVID-19) pill suggest it is less effective than previously reported. The company will now move forward to test the treatment for safety. The pill molnupiravir showed only a 30 percent reduction in hospitalization and death based on data from 1,400 patients. Figures … Continue reading Merck admits COVID pills are not nearly as effective as advertised
Doctor says US “wasting money” on coronavirus drug from Merck
A critical care doctor said the U.S. is wasting taxpayer’s money on its purchase of drug manufacturer Merck’s Wuhan coronavirus (COVID-19) antiviral treatment. Front Line COVID-19 Critical Care Alliance (FLCCC) President Dr. Pierre Kory warned that the Biden administration should not pay Merck for a COVID-19 drug “which has already failed in hospitalized patients.” He instead called for … Continue reading Doctor says US “wasting money” on coronavirus drug from Merck
Dr. Eddy Bettermann MD 